Form 4: Xeris Biopharma Director Ricki Louise Fairley Reports Stock Award and Disposal

Director Ricki Louise Fairley reports acquisition of 50,000 shares of Xeris Biopharma Holdings, Inc. through a restricted stock unit award and disposal of 135,000 shares.

Summary

• On June 5, 2024, Ricki Louise Fairley, a director of Xeris Biopharma Holdings, Inc., reported a transaction involving the company's common stock.
• Fairley acquired 50,000 shares through a restricted stock unit (RSU) award under the company's 2018 Stock Option and Incentive Plan.
• The RSUs represent a contingent right to receive one share of Xeris Biopharma's common stock each.
• These shares will vest on June 5, 2025, or at the company's next annual meeting of stockholders, whichever comes first.
• Fairley also disposed of 135,000 shares.
• Following these transactions, Fairley beneficially owns 135,000 shares of Xeris Biopharma Holdings, Inc.

Sentiment

Score: 5

Explanation: Neutral sentiment. The document primarily reports transactions without expressing a clear positive or negative outlook. The acquisition of RSUs is generally positive, but the disposal of shares tempers the overall sentiment.

Positives

• The acquisition of shares via restricted stock units aligns the director's interests with those of the company and its shareholders.

Negatives

• The disposal of 135,000 shares by the director could be interpreted negatively by the market.

Risks

• The vesting of the restricted stock units is contingent upon continued service or the occurrence of the next annual meeting, which introduces a time-based risk.

Future Outlook

The vesting of the restricted stock units in 2025 or at the next annual meeting represents a future event that could impact the director's holdings.

Industry Context

Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• Shareholders may react to the director's stock disposal, potentially influencing the stock price.

Key Dates